211 related articles for article (PubMed ID: 25400928)
1. A pilot study showing differences in glycosylation patterns of IgG subclasses induced by pneumococcal, meningococcal, and two types of influenza vaccines.
Vestrheim AC; Moen A; Egge-Jacobsen W; Reubsaet L; Halvorsen TG; Bratlie DB; Paulsen BS; Michaelsen TE
Immun Inflamm Dis; 2014 Aug; 2(2):76-91. PubMed ID: 25400928
[TBL] [Abstract][Full Text] [Related]
2. Changes in antigen-specific IgG1 Fc N-glycosylation upon influenza and tetanus vaccination.
Selman MH; de Jong SE; Soonawala D; Kroon FP; Adegnika AA; Deelder AM; Hokke CH; Yazdanbakhsh M; Wuhrer M
Mol Cell Proteomics; 2012 Apr; 11(4):M111.014563. PubMed ID: 22184099
[TBL] [Abstract][Full Text] [Related]
3. mRNA vaccines against SARS-CoV-2 induce comparably low long-term IgG Fc galactosylation and sialylation levels but increasing long-term IgG4 responses compared to an adenovirus-based vaccine.
Buhre JS; Pongracz T; Künsting I; Lixenfeld AS; Wang W; Nouta J; Lehrian S; Schmelter F; Lunding HB; Dühring L; Kern C; Petry J; Martin EL; Föh B; Steinhaus M; von Kopylow V; Sina C; Graf T; Rahmöller J; Wuhrer M; Ehlers M
Front Immunol; 2022; 13():1020844. PubMed ID: 36713457
[TBL] [Abstract][Full Text] [Related]
4. Human IgG subclass responses in relation to serum bactericidal and opsonic activities after immunization with three doses of the Norwegian serogroup B meningococcal outer membrane vesicle vaccine.
Naess LM; Aarvak T; Aase A; Oftung F; Høiby EA; Sandin R; Michaelsen TE
Vaccine; 1999 Feb; 17(7-8):754-64. PubMed ID: 10067680
[TBL] [Abstract][Full Text] [Related]
5. Opsonophagocytic and bactericidal activity mediated by purified IgG subclass antibodies after vaccination with the Norwegian group B meningococcal vaccine.
Aase A; Høiby EA; Michaelsen TE
Scand J Immunol; 1998 Apr; 47(4):388-96. PubMed ID: 9600322
[TBL] [Abstract][Full Text] [Related]
6. IgG Fc sialylation is regulated during the germinal center reaction following immunization with different adjuvants.
Bartsch YC; Eschweiler S; Leliavski A; Lunding HB; Wagt S; Petry J; Lilienthal GM; Rahmöller J; de Haan N; Hölscher A; Erapaneedi R; Giannou AD; Aly L; Sato R; de Neef LA; Winkler A; Braumann D; Hobusch J; Kuhnigk K; Krémer V; Steinhaus M; Blanchard V; Gemoll T; Habermann JK; Collin M; Salinas G; Manz RA; Fukuyama H; Korn T; Waisman A; Yogev N; Huber S; Rabe B; Rose-John S; Busch H; Berberich-Siebelt F; Hölscher C; Wuhrer M; Ehlers M
J Allergy Clin Immunol; 2020 Sep; 146(3):652-666.e11. PubMed ID: 32445838
[TBL] [Abstract][Full Text] [Related]
7. IgG subclass antibodies to serogroup B meningococcal outer membrane antigens following infection and vaccination.
Sjursen H; Wedege E; Rosenqvist E; Naess A; Halstensen A; Matre R; Solberg CO
APMIS; 1990 Dec; 98(12):1061-9. PubMed ID: 2126441
[TBL] [Abstract][Full Text] [Related]
8. IgG antibody subclass responses determined by immunoblot in infants' sera following vaccination with a meningococcal recombinant hexavalent PorA OMV vaccine.
Martin S; Sadler F; Borrow R; Dawson M; Fox A; Cartwright K
Vaccine; 2001 Aug; 19(31):4404-8. PubMed ID: 11483265
[TBL] [Abstract][Full Text] [Related]
9. Fc specific IgG glycosylation profiling by robust nano-reverse phase HPLC-MS using a sheath-flow ESI sprayer interface.
Selman MH; Derks RJ; Bondt A; Palmblad M; Schoenmaker B; Koeleman CA; van de Geijn FE; Dolhain RJ; Deelder AM; Wuhrer M
J Proteomics; 2012 Feb; 75(4):1318-29. PubMed ID: 22120122
[TBL] [Abstract][Full Text] [Related]
10. Antibody avidity and immunoglobulin G isotype distribution following immunization with a monovalent meningococcal B outer membrane vesicle vaccine.
Vermont CL; van Dijken HH; van Limpt CJ; de Groot R; van Alphen L; van Den Dobbelsteen GP
Infect Immun; 2002 Feb; 70(2):584-90. PubMed ID: 11796586
[TBL] [Abstract][Full Text] [Related]
11. Quantitative analysis of immunoglobulin subclasses and subclass specific glycosylation by LC-MS-MRM in liver disease.
Yuan W; Sanda M; Wu J; Koomen J; Goldman R
J Proteomics; 2015 Feb; 116():24-33. PubMed ID: 25582524
[TBL] [Abstract][Full Text] [Related]
12. Glycomic signatures on serum IgGs for prediction of postvaccination response.
Wang JR; Guan WD; Yau LF; Gao WN; Zhan YQ; Liu L; Yang ZF; Jiang ZH
Sci Rep; 2015 Jan; 5():7648. PubMed ID: 25612906
[TBL] [Abstract][Full Text] [Related]
13. Anti-SARS-CoV-2 antibodies elicited by COVID-19 mRNA vaccine exhibit a unique glycosylation pattern.
Farkash I; Feferman T; Cohen-Saban N; Avraham Y; Morgenstern D; Mayuni G; Barth N; Lustig Y; Miller L; Shouval DS; Biber A; Kirgner I; Levin Y; Dahan R
Cell Rep; 2021 Dec; 37(11):110114. PubMed ID: 34883043
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive analysis of
Zou G; Kosikova M; Kim SR; Kotian S; Wu WW; Shen R; Powers DN; Agarabi C; Xie H; Ju T
J Biol Chem; 2018 Dec; 293(50):19277-19289. PubMed ID: 30315103
[TBL] [Abstract][Full Text] [Related]
15. IgG subclass and vaccination stimulus determine changes in antigen specific antibody glycosylation in mice.
Kao D; Lux A; Schaffert A; Lang R; Altmann F; Nimmerjahn F
Eur J Immunol; 2017 Dec; 47(12):2070-2079. PubMed ID: 28771702
[TBL] [Abstract][Full Text] [Related]
16. Immunologic priming of young children by pneumococcal glycoprotein conjugate, but not polysaccharide, vaccines.
O'Brien KL; Steinhoff MC; Edwards K; Keyserling H; Thoms ML; Madore D
Pediatr Infect Dis J; 1996 May; 15(5):425-30. PubMed ID: 8724065
[TBL] [Abstract][Full Text] [Related]
17. IgG subclasses and avidity of antibodies to polysaccharide antigens in allogeneic BMT recipients after vaccination with pneumococcal polysaccharide and Haemophilus influenzae type b conjugate vaccines.
Parkkali T; Käyhty H; Anttila M; Ruutu T; Wuorimaa T; Soininen A; Volin L; Ruutu P
Bone Marrow Transplant; 1999 Sep; 24(6):671-8. PubMed ID: 10490735
[TBL] [Abstract][Full Text] [Related]
18. MS-Based Allotype-Specific Analysis of Polyclonal IgG-Fc
Sénard T; Gargano AFG; Falck D; de Taeye SW; Rispens T; Vidarsson G; Wuhrer M; Somsen GW; Domínguez-Vega E
Front Immunol; 2020; 11():2049. PubMed ID: 32973813
[TBL] [Abstract][Full Text] [Related]
19. Human antibody responses to meningococcal outer membrane antigens after three doses of the Norwegian group B meningococcal vaccine.
Rosenqvist E; Høiby EA; Wedege E; Bryn K; Kolberg J; Klem A; Rønnild E; Bjune G; Nøkleby H
Infect Immun; 1995 Dec; 63(12):4642-52. PubMed ID: 7591118
[TBL] [Abstract][Full Text] [Related]
20. The
de Haan N; Reiding KR; Krištić J; Hipgrave Ederveen AL; Lauc G; Wuhrer M
Front Immunol; 2017; 8():608. PubMed ID: 28620376
[No Abstract] [Full Text] [Related]
[Next] [New Search]
